Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in INO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$98,939
-$337,714 QoQ
Shares Held
56,862
-77.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Mar 31, 2026
CallValue
$467,538
CallShares
268,700
PutValue
$235,074
PutShares
135,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,173,997,525 across 354 Biotechnology names. INO ranks #313 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $467,538 268,700
2026-03-31 $235,074 135,100
2026-03-31 $98,939 56,862
2025-12-31 $70,992 40,800
2025-12-31 $124,062 71,300
2025-12-31 $436,653 250,950
2025-09-30 $53,352 22,800
2025-09-30 $119,765 51,182
2025-09-30 $415,116 177,400
2025-06-30 $27,948 13,700
2025-06-30 $98,532 48,300
2025-06-30 $308,584 151,267
2025-03-31 $316,824 194,371
2024-12-31 $25,254 13,800
2024-12-31 $77,172 42,171
2024-12-31 $242,475 132,500
2024-09-30 $1,110,338 192,100
2024-09-30 $173,810 30,071
2024-09-30 $538,696 93,200
2024-06-30 $985,760 122,000
2024-06-30 $2,043,432 252,900
2024-03-31 $3,295,112 237,400
2024-03-31 $3,586,592 258,400
2024-03-31 $203,952 14,694